Phase II trial of S-1 and lentinan combined chemotherapy for elderly patients with unresectable advanced gastric cancer
Phase 2
- Conditions
- nresectable advanced gastric cancer
- Registration Number
- JPRN-UMIN000026975
- Lead Sponsor
- Saitama Medical Center, Saitama Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 38
Inclusion Criteria
Not provided
Exclusion Criteria
1.Administration contraindication of S-1 2.Active infectious 3.Serious heart disease or the past history 4.Serious coexisting illness 5.Massive abdominal or pleural effusion 6.Multiple bone metastases 7.Brain metastasis or the past history 8.Active gastrointestinal bleeding 9. Mental disorder to need a psychotropic drug 10. Hypersensitivity to lentinan 11.Inappropriate patients for this study judged by the physicians
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overall survival
- Secondary Outcome Measures
Name Time Method